Breast Adenocarcinoma — Trials

Breast Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,711 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 381
Ph III recruiting: 44
Growth YoY: +8.6%
Industry share: 24%
Top sponsor: Fudan University
Termination share: 44.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (277)

clinicaltrialsPublishedShowing 1–50 of 212 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02498613	A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors	active not recruiting	Phase 2	122	National Cancer Institute (NCI)NIH	2	Sep 25, 2026	clinicaltrials
NCT04090398	Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones	active not recruiting	Phase 2	70	National Cancer Institute (NCI)NIH	1	Sep 18, 2026